Since last year, EFCNI has been involved as a third party representing the voice of patients and parents in the new conect4children (c4c) consortium, a research collaboration to build a European paediatric clinical trial network that aims to facilitate the development of new drugs and other therapies for the entire paediatric population. c4c now announced that it selected its first portfolio of pan-European paediatric studies aimed at advancing the understanding of high priority medicines commonly used in babies, children, and young people in Europe.…